Carregant...
Creation of a Long-Acting Rilpivirine Prodrug Nanoformulation
Antiretroviral therapy requires lifelong daily dosing to attain viral suppression, restore immune function, and improve quality of life. As a treatment alternative, long-acting (LA) antiretrovirals can sustain therapeutic drug concentrations in blood for prolonged time periods. The success of recent...
Guardat en:
| Publicat a: | J Control Release |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6875695/ https://ncbi.nlm.nih.gov/pubmed/31491432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2019.09.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|